Advocacy intelligence hub — real-time data for patient organizations
Tasly Pharmaceutical Group Co., Ltd — PHASE1, PHASE2
University of California, Los Angeles — PHASE1
University Hospital, Bonn — PHASE3
Washington University School of Medicine
TVAX Biomedical — PHASE2, PHASE3
Novelwise Pharmaceutical Corporation — PHASE1, PHASE2
Dushu Lake Hospital Affiliated to Soochow University — PHASE1, PHASE2
West Virginia University — PHASE1, PHASE2
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — PHASE1
Beijing Tiantan Hospital — PHASE1
Data from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.
FINANCIAL LANDSCAPE SUMMARY
Total programs
Open now
Patient Assistance Programs1
Temodar
Schering-Plough Research Institute
Temodar
(temozolomide)Orphan drugstandardSchering-Plough Research Institute
Alkylating Drug [EPC]
12.1 Mechanism of Action Temozolomide is not directly active but undergoes rapid nonenzymatic conversion at physiologic pH to the reactive compound 5-...
David Peereboom, MD, M.D
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
📍 CLEVELAND, OH
Phioanh Nghiemphu, MD
University of California at Los Angeles (UCLA )
📍 LOS ANGELES, CA
Patrick Y Wen, MD
National Cancer Institute (NCI)
📍 BOSTON, MA
Jana Portnow, MD
City of Hope Medical Center
📍 DUARTE, CA
Ernest C. Borden, MD
Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Cancer Center
Patrick Wen, MD, MD
National Cancer Institute (NCI)
📍 BOSTON, MA